Jasmin Bektić

4.0k total citations
108 papers, 3.0k citations indexed

About

Jasmin Bektić is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jasmin Bektić has authored 108 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Pulmonary and Respiratory Medicine, 18 papers in Rheumatology and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jasmin Bektić's work include Prostate Cancer Treatment and Research (65 papers), Prostate Cancer Diagnosis and Treatment (59 papers) and Urologic and reproductive health conditions (14 papers). Jasmin Bektić is often cited by papers focused on Prostate Cancer Treatment and Research (65 papers), Prostate Cancer Diagnosis and Treatment (59 papers) and Urologic and reproductive health conditions (14 papers). Jasmin Bektić collaborates with scholars based in Austria, United States and Italy. Jasmin Bektić's co-authors include Wolfgang Horninger, Helmut Klocker, Georg Bartsch, Alexandré Pelzer, Andreas P. Berger, Georg Schäfer, Ferdinand Frauscher, Hannes Steiner, Georg Bartsch and Friedrich Aigner and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and The American Journal of Human Genetics.

In The Last Decade

Jasmin Bektić

97 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jasmin Bektić Austria 32 2.0k 690 654 424 421 108 3.0k
Kazuto Ito Japan 32 1.7k 0.9× 210 0.3× 730 1.1× 323 0.8× 466 1.1× 160 3.0k
Antti Rannikko Finland 32 2.8k 1.4× 377 0.5× 1.1k 1.7× 579 1.4× 762 1.8× 148 4.4k
Carlo Buonerba Italy 32 1.2k 0.6× 257 0.4× 732 1.1× 575 1.4× 622 1.5× 123 2.7k
Naoki Terada Japan 29 1.2k 0.6× 144 0.2× 878 1.3× 391 0.9× 267 0.6× 145 2.6k
Seiichiro Ozono Japan 35 1.4k 0.7× 174 0.3× 973 1.5× 478 1.1× 493 1.2× 207 3.5k
Toshiyuki Kamoto Japan 37 1.6k 0.8× 168 0.2× 1.4k 2.1× 602 1.4× 840 2.0× 262 3.9k
Nobumichi Tanaka Japan 29 1.3k 0.7× 154 0.2× 656 1.0× 314 0.7× 649 1.5× 248 3.0k
Hidefumi Kinoshita Japan 25 1.3k 0.7× 127 0.2× 914 1.4× 403 1.0× 510 1.2× 222 2.8k
Ke‐Hung Tsui Taiwan 29 1.2k 0.6× 114 0.2× 1.2k 1.9× 470 1.1× 373 0.9× 102 2.5k
Hao G. Nguyen United States 26 969 0.5× 236 0.3× 881 1.3× 307 0.7× 356 0.8× 112 2.3k

Countries citing papers authored by Jasmin Bektić

Since Specialization
Citations

This map shows the geographic impact of Jasmin Bektić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmin Bektić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmin Bektić more than expected).

Fields of papers citing papers by Jasmin Bektić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasmin Bektić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmin Bektić. The network helps show where Jasmin Bektić may publish in the future.

Co-authorship network of co-authors of Jasmin Bektić

This figure shows the co-authorship network connecting the top 25 collaborators of Jasmin Bektić. A scholar is included among the top collaborators of Jasmin Bektić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmin Bektić. Jasmin Bektić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steinkohl, Fabian, Anna Luger, Leonhard Gruber, et al.. (2024). Patients’ anxieties and fears: a comparison between transrectal prostate biopsy and prostate MRI. Translational Andrology and Urology. 13(10). 2201–2208.
2.
Seklehner, Stephan, et al.. (2022). Transurethral resection of the prostate in 85+ patients: a retrospective, multicentre study. World Journal of Urology. 40(12). 3015–3020. 11 indexed citations
3.
4.
Mair, Christian, et al.. (2020). 転移性去勢抵抗性前立腺癌のPSMA標的化における68Ga/177Lu-セラノスティクス概念:フォローアップにおける治療後全身シンチグラフィーの影響【JST・京大機械翻訳】. European Journal of Nuclear Medicine and Molecular Imaging. 47(3). 695–712. 5 indexed citations
5.
Uprimny, Christian, Alexander Kroiss, Josef Fritz, et al.. (2017). Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence. European Journal of Nuclear Medicine and Molecular Imaging. 44(10). 1647–1655. 43 indexed citations
6.
Ponholzer, Anton, Wolfgang Loidl, Jasmin Bektić, et al.. (2016). Austrian recommendations on Targeted Hormone Therapy for metastatic, castration-resistant prostate cancer. Wiener klinische Wochenschrift. 128(3-4). 156–163. 4 indexed citations
7.
Heidegger, Isabel, Eberhard Steiner, Helmut Klocker, et al.. (2015). High Risk of Under-Grading and -Staging in Prostate Cancer Patients Eligible for Active Surveillance. PLoS ONE. 10(2). e0115537–e0115537. 20 indexed citations
8.
Sooriakumaran, Prasanna, Majnu John, Paul J. Christos, et al.. (2011). Models to Predict Positive Prostate Biopsies Using the Tyrol Screening Study. Urology. 78(4). 924–929. 4 indexed citations
9.
Kloss‐Brandstätter, Anita, Georg Schäfer, Gertraud Erhart, et al.. (2010). Somatic Mutations throughout the Entire Mitochondrial Genome Are Associated with Elevated PSA Levels in Prostate Cancer Patients. The American Journal of Human Genetics. 87(6). 802–812. 72 indexed citations
10.
Pelzer, Alexandré, Daniela Colleselli, Jasmin Bektić, et al.. (2008). Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate‐specific antigen level: is there a difference?. British Journal of Urology. 101(7). 822–825. 8 indexed citations
11.
Bartsch, Georg, Wolfgang Horninger, Helmut Klocker, et al.. (2008). Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality. British Journal of Urology. 101(7). 809–816. 103 indexed citations
12.
Pelzer, Alexandré, Daniela Colleselli, Jasmin Bektić, et al.. (2008). Over‐diagnosis and under‐diagnosis of screen‐ vs non‐screen‐detected prostate cancers with in men with prostate‐specific antigen levels of 2.0–10.0 ng/mL. British Journal of Urology. 101(10). 1223–1226. 6 indexed citations
13.
Berger, Andreas P., Martina Deibl, Alexander Strasak, et al.. (2007). Large-Scale Study of Clinical Impact of PSA Velocity: Long-Term PSA Kinetics as Method of Differentiating Men with from Those without Prostate Cancer. Urology. 69(1). 134–138. 33 indexed citations
14.
O’Toole, Sharon, Elizabeth Dunn, Brian Sheppard, et al.. (2006). Genome-wide analysis of deoxyribonucleic acid in endometrial cancer using comparative genomic hybridization microarrays. International Journal of Gynecological Cancer. 16(2). 834–842. 11 indexed citations
15.
Steiner, Hannes, Ilaria T. Cavarretta, Patrizia Moser, et al.. (2006). Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328. The Prostate. 66(16). 1744–1752. 36 indexed citations
16.
Pelzer, Alexandré, Hubert Volgger, Jasmin Bektić, et al.. (2005). The effect of percentage free prostate‐specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels. British Journal of Urology. 96(7). 995–998. 29 indexed citations
17.
Bektić, Jasmin, Reinhold Ramoner, Alexandré Pelzer, et al.. (2005). Small G‐protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis. The Prostate. 64(4). 332–340. 72 indexed citations
18.
Frauscher, Ferdinand, Leo Pallwein, Andrea Klauser, et al.. (2005). Ultraschallkontrastmittel und Prostatakarzinom. Der Radiologe. 45(6). 544–551. 10 indexed citations
19.
Berger, Andreas P., Martina Deibl, Hannes Steiner, et al.. (2005). Longitudinal PSA changes in men with and without prostate cancer: Assessment of prostate cancer risk. The Prostate. 64(3). 240–245. 43 indexed citations
20.
Berger, Angelika, Martina Deibl, Ethan J. Halpern, et al.. (2005). Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia. Diabetologia. 48(4). 784–789. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuto Ito Breakdown of academic impact, for papers by Antti Rannikko Breakdown of academic impact, for papers by Carlo Buonerba Breakdown of academic impact, for papers by Naoki Terada Breakdown of academic impact, for papers by Seiichiro Ozono Breakdown of academic impact, for papers by Toshiyuki Kamoto Breakdown of academic impact, for papers by Nobumichi Tanaka Breakdown of academic impact, for papers by Hidefumi Kinoshita Breakdown of academic impact, for papers by Ke‐Hung Tsui Breakdown of academic impact, for papers by Hao G. Nguyen
Rankless by CCL
2026